PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

As India grapples with an escalating diabetes crisis, with 101 million1 diagnosed and 136 million with pre-diabetes, the ...

Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...

A new study published in the Nature Scientific Reports showed that compared to kidney recipients who got preemptive transplants, individuals who experienced dialysis prior to transplantation are ...

Statistical analysis showed a strong association between advanced diabetic retinopathy and an increased likelihood of heart ...

Cloudy vision can develop for several reasons, including cataracts, macular degeneration, and inflammatory eye conditions.

Integrating IRIS technologies will allow Topcon to improve retinal disease diagnostics and referrals from primary care ...

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could ...

Diabetes progression indicators, including chronic kidney disease and prolonged diabetes duration, were associated with greater kidney cancer risk.